Evidence map›Paper›PMID 28403548›Full record

ArticleCancer science2017

Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.

Ryo Funayama, Hajime Taniguchi, Masamichi Mizuma, Fumiyoshi Fujishima, Minoru Kobayashi, Shinobu Ohnuma, Michiaki Unno, Keiko Nakayama

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Citrullination and the protein code: crosstalk between post-translational modifications in cancer.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  6. Inhibiting MEK1 R189 citrullination enhances the chemosensitivity of docetaxel to multiple tumour cells.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ryo FunayamaDepartment of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, ART, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Hajime TaniguchiDepartment of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, ART, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Masamichi MizumaDepartment of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Fumiyoshi FujishimaDepartment of Anatomic Pathology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Minoru KobayashiDepartment of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, ART, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Shinobu OhnumaDepartment of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Michiaki UnnoDepartment of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Keiko NakayamaDepartment of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, ART, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expression of the gene for protein-arginine deiminase 2 (PADI2) has been shown to be downregulated in colon cancer, with such downregulation being indicative of a poor prognosis in individuals with this disease. We have now examined the expression of PADI2 in matched colon cancer and normal colon tissue specimens as well as in colon cancer cell lines. We found that isoform 1 of PADI2 is the predominant isoform in colon tissue and is downregulated during colon carcinogenesis. Immunohistochemical analysis showed that PADI2 is expressed in normal colonic epithelial cells. Overexpression of PADI2 isoform 1 suppressed the proliferation of colon cancer cells in vitro in association with increased protein citrullination. Expression of a catalytically inactive mutant (C647A) of PADI2 or of PADI2 isoform 2 did not induce such effects, indicating that the protein citrullination activity of PADI2 is required for inhibition of cell growth. The growth defect induced by PADI2 was not attributable to increased apoptosis but rather was accompanied by arrest of cell cycle progression in G

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedCell Line, TumorCell ProliferationCitrullineColonic NeoplasmsDown-RegulationFemaleG1 Phase Cell Cycle CheckpointsHCT116 CellsHumansHydrolasesImmunoblottingImmunohistochemistryIsoenzymesCitrullineHydrolasesIsoenzymesPADI2 protein, humanProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 2Cell proliferationcolorectal cancerepigenomic regulationPADI2protein citrullination

Identifiers

PMID28403548
PMCPMC5406534
OpenAlexW2583858744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.